PERSEUSPUR LLC 4
4 · MAP Pharmaceuticals, Inc. · Filed May 13, 2010
Insider Transaction Report
Form 4
PERSEUSPUR LLC
10% Owner
Transactions
- Other
Common Stock
2010-05-11−933,004→ 1,893,165 total(indirect: See Footnotes)
Footnotes (2)
- [F1]All of the securities reported herein are held for the account of Perseus-Soros BioPharmaceutical Fund, LP ("Perseus-Soros"), Perseus Biotech Investment, LLC ("PBI"), Perseus Biotech Fund Partners, LLC ("Perseus Biotech Fund Partners"), and Biotech Management Partners, LLC ("Biotech Management Partners"). Perseus BioTech Fund Partners is a managing member of Biotech Management Partners. Perseuspur L.L.C. ("Perseuspur")is the managing member of PBI and Perseus Biotech Fund Partners. Frank H. Pearl is the managing member of Perseuspur.
- [F2]On May 11, 2010, Perseus-Soros distributed 1,000,000 shares of the Issuer's Common Stock pro rata to its partners for no consideration and certain partners of Perseus-Soros have made subsequent pro rata distributions to their respective partners or members for no consideration (collectively, the "Distributions"). As a result of the Distributions, Perseus Biotech Fund Partners now holds 1,024 shares of the Issuer's Common Stock, Biotech Management Partners now holds 89 shares of the Issuer's Common Stock, PBI now holds 65,883 shares of the Issuer's Common Stock, and Perseus-Soros now holds 1,826,169 shares of the Issuer's Common Stock.